Abstract
BackgroundThe addition of cetuximab significantly increased the antitumor effect of programmed cell death protein 1 (PD-1) inhibitors in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). However, preliminary...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have